Efficacy of 2-halogen substituted d -glucose analogs in blocking glycolysis and killing “hypoxic tumor cells”

Abstract   Purpose: Since 2-deoxy-D-glucose (2-DG) is currently in phase I clinical trials to selectively target slow-growing hypoxic tumor cells, 2-halogenated D-glucose analogs were synthesized for improved activity. Given the f